2023 - Research.com Immunology in Germany Leader Award
Ezio Bonifacio mostly deals with Immunology, Autoantibody, Diabetes mellitus, Type 1 diabetes and Internal medicine. His study in Immunology is interdisciplinary in nature, drawing from both Transplantation and Islet. His study focuses on the intersection of Autoantibody and fields such as Antigen with connections in the field of Cell culture and Interferon.
His Diabetes mellitus research incorporates elements of Natural history and Insulin. His Type 1 diabetes study incorporates themes from Receiver operating characteristic and Breast feeding. His Internal medicine study integrates concerns from other disciplines, such as Glutamate decarboxylase, Endocrinology and Gastroenterology.
Ezio Bonifacio focuses on Immunology, Type 1 diabetes, Autoantibody, Diabetes mellitus and Internal medicine. Immunology is often connected to Islet in his work. The concepts of his Type 1 diabetes study are interwoven with issues in Human leukocyte antigen, Disease, Immune system and Pediatrics.
His Autoantibody research incorporates themes from Glutamate decarboxylase, Epitope and Seroconversion. His Diabetes mellitus study incorporates themes from Offspring, Pregnancy, Insulin and Risk factor. Ezio Bonifacio interconnects Gastroenterology, Endocrinology and Diabetes risk in the investigation of issues within Internal medicine.
Ezio Bonifacio mainly focuses on Type 1 diabetes, Diabetes mellitus, Immunology, Autoantibody and Internal medicine. His work deals with themes such as Autoimmunity, Insulin, Family history and Pediatrics, which intersect with Type 1 diabetes. His work on Diabetic ketoacidosis as part of general Diabetes mellitus research is frequently linked to Hazard ratio, bridging the gap between disciplines.
The Immunology study combines topics in areas such as Regulation of gene expression, Type 2 diabetes and Islet. His work is dedicated to discovering how Autoantibody, Incidence are connected with Gastroenterology, Gluten intake and Increased risk and other disciplines. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and HLA-DR3.
His primary scientific interests are in Type 1 diabetes, Diabetes mellitus, Immunology, Internal medicine and Autoantibody. He combines subjects such as Computational biology, Omics and Public health with his study of Type 1 diabetes. His study ties his expertise on Human leukocyte antigen together with the subject of Diabetes mellitus.
His studies deal with areas such as Type 2 diabetes and Islet as well as Immunology. His Islet research includes elements of HNF1A, Pancreas and Impaired glucose tolerance. His biological study spans a wide range of topics, including Seroconversion, Insulin and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler;Marian Rewers;Olli Simell;Tuula Simell.
JAMA (2013)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
Jonas Schulte-Schrepping;Nico Reusch;Daniela Paclik;Kevin Baßler.
Cell (2020)
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
Valeria Sordi;Maria Luisa Malosio;Maria Luisa Malosio;Federica Marchesi;Federica Marchesi;Alessia Mercalli;Alessia Mercalli.
Blood (2005)
Early Infant Feeding and Risk of Developing Type 1 Diabetes-Associated Autoantibodies
Anette-G. Ziegler;Sandra Schmid;Doris Huber;Michael Hummel.
JAMA (2003)
Type 1 Diabetes Mellitus
Anastasia Katsarou;Soffia Gudbjörnsdottir;Araz Rawshani;Dana Dabelea.
Nature Reviews Disease Primers (2017)
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.
A G Ziegler;M Hummel;M Schenker;E Bonifacio.
Diabetes (1999)
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow.
Diabetes (2017)
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
C F Verge;D Stenger;E Bonifacio;P G Colman.
Diabetes (1998)
Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers
Polly J Bingley;Ezio Bonifacio;Alistair J K Williams;Stefano Genovese.
Diabetes (1997)
Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives
Polly J. Bingley;Michael R. Christie;Ezio Bonifacio;Ricardo Bonfanti.
Diabetes (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Technical University of Munich
Lund University
Vita-Salute San Raffaele University
University of Colorado Denver
University of Turku
University of South Florida
University of Florida
University of Helsinki
University of Colorado Denver
Jinfiniti Precision Medicine
University of Washington
University of Parma
Italian Institute of Technology
University of North Carolina at Greensboro
University of Chinese Academy of Sciences
Adobe Systems (United States)
Kyushu University
University of Chicago
Freie Universität Berlin
Brown University
University of North Carolina at Chapel Hill
University at Buffalo, State University of New York
Monash University
Duke University
Mayo Clinic
University of North Carolina at Chapel Hill